# DSIP dosage guide

> Review DSIP dosage information by administration route, with source-linked dose and schedule details.

Canonical: https://pepflow.app/peptides/dsip/dosage/

Compare DSIP injection schedules, the Deltaran nasal formulation and transdermal delivery preparations, including bedtime timing. Calculate volume and syringe units using your own vial inputs.

[Full DSIP library reference](<https://pepflow.app/peptides/dsip/>)

## DSIP dosage chart

This summary table compares available dose amounts and schedules by administration route.

| Route | Dose | Frequency & duration |
| --- | --- | --- |
| Injectable | 100–300 mcg | Nightly · 2–6 wk |
| Intranasal | 300 mcg (Deltaran) | Once daily · 5 days |
| Transdermal | 3.5 mL of 0.2 mg/mL donor solution (0.7 mg loaded) | Single laboratory exposure · 9-hour sampling period |

## DSIP dosage by administration route

### DSIP injectable dosage

Reported-use amounts for DSIP are 100–300 mcg per administration, nightly, for 2–6 wk. Another reported subcutaneous amount is 200–400 mcg daily in 5–10-day courses. This is a separate shorter pattern from the 2–6-week injectable course above and is not interchangeable with the Deltaran nasal formulation.[\[12\]](<https://pepflow.app/peptides/dsip/dosage/#source-12>) [\[13\]](<https://pepflow.app/peptides/dsip/dosage/#source-13>)

DSIP is a nine-amino-acid peptide associated with sleep and stress-response signaling. Proposed sleep effects do not establish a dependable insomnia treatment.[\[1\]](<https://pepflow.app/peptides/dsip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/dsip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/dsip/dosage/#source-3>) [\[12\]](<https://pepflow.app/peptides/dsip/dosage/#source-12>)

### DSIP intranasal — deltaran formulation dosage

The documented Deltaran nasal formulation uses 300 mcg once daily for five days. Its concentration and directions define a separate preparation from injectable DSIP.[\[11\]](<https://pepflow.app/peptides/dsip/dosage/#source-11>)

DSIP is a nine-amino-acid peptide associated with sleep and stress-response signaling. Proposed sleep effects do not establish a dependable insomnia treatment.[\[5\]](<https://pepflow.app/peptides/dsip/dosage/#source-5>) [\[11\]](<https://pepflow.app/peptides/dsip/dosage/#source-11>) [\[1\]](<https://pepflow.app/peptides/dsip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/dsip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/dsip/dosage/#source-3>)

### DSIP transdermal — ex vivo iontophoresis dosage

The iontophoresis experiment loads 3.5 mL of 0.2 mg/mL DSIP solution into the donor chamber, totaling 0.7 mg over 0.785 cm² of excised rabbit-ear skin. Samples are collected over 9 hours while pH, current and enzyme inhibitors are compared. This is a laboratory reservoir amount, not a sleep-treatment patch dose.[\[6\]](<https://pepflow.app/peptides/dsip/dosage/#source-6>)

The experiment uses cathodal iontophoresis rather than a passive adhesive patch. Its donor concentration, enzyme-inhibitor conditions and measured skin flux describe a laboratory delivery system.[\[6\]](<https://pepflow.app/peptides/dsip/dosage/#source-6>) [\[1\]](<https://pepflow.app/peptides/dsip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/dsip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/dsip/dosage/#source-3>)

### Frequency and timing

The injection pattern is timed 30–60 minutes before bed. The Deltaran nasal formulation and experimental transdermal preparation follow their separate administration schedules.[\[4\]](<https://pepflow.app/peptides/dsip/dosage/#source-4>) [\[1\]](<https://pepflow.app/peptides/dsip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/dsip/dosage/#source-2>) [\[5\]](<https://pepflow.app/peptides/dsip/dosage/#source-5>) [\[11\]](<https://pepflow.app/peptides/dsip/dosage/#source-11>) [\[12\]](<https://pepflow.app/peptides/dsip/dosage/#source-12>) [\[6\]](<https://pepflow.app/peptides/dsip/dosage/#source-6>)

### Cycle length and breaks

Injectable: 2–6 wk. Intranasal — Deltaran formulation: 5 days. Transdermal — ex vivo iontophoresis: 9-hour sampling period. A standard break interval between courses is not established.[\[12\]](<https://pepflow.app/peptides/dsip/dosage/#source-12>) [\[11\]](<https://pepflow.app/peptides/dsip/dosage/#source-11>) [\[6\]](<https://pepflow.app/peptides/dsip/dosage/#source-6>)

## DSIP dosage calculator

Convert your chosen DSIP amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.

For preparation terms and concentration basics, see the [reconstitution guidelines](<https://pepflow.app/peptide-reconstitution-guidelines/>). Follow the arithmetic in the [concentration calculation walkthrough](<https://pepflow.app/blog/how-to-calculate-final-concentration/>).

## DSIP safety and side effects

### Approval and product quality

DSIP is not an FDA-approved drug.[\[4\]](<https://pepflow.app/peptides/dsip/dosage/#source-4>) [\[8\]](<https://pepflow.app/peptides/dsip/dosage/#source-8>) [\[9\]](<https://pepflow.app/peptides/dsip/dosage/#source-9>) [\[10\]](<https://pepflow.app/peptides/dsip/dosage/#source-10>)

### Side effects and long-term safety

Next-day sedation, dream changes and headache are practical tolerability concerns. Modern dose-ranging, interactions, long-term sleep effects and safety in special populations remain insufficiently characterized.[\[1\]](<https://pepflow.app/peptides/dsip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/dsip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/dsip/dosage/#source-3>) [\[7\]](<https://pepflow.app/peptides/dsip/dosage/#source-7>)

### Route-specific dosing limits

Sedative overlap and underlying sleep or mood disorders are the key safety contexts. Reported-use injectable schedules and additional protocol patterns are not established human treatment regimens or approved product instructions.[\[1\]](<https://pepflow.app/peptides/dsip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/dsip/dosage/#source-2>) [\[3\]](<https://pepflow.app/peptides/dsip/dosage/#source-3>) [\[7\]](<https://pepflow.app/peptides/dsip/dosage/#source-7>) [\[13\]](<https://pepflow.app/peptides/dsip/dosage/#source-13>) [\[12\]](<https://pepflow.app/peptides/dsip/dosage/#source-12>)

## Common DSIP dosage questions

### Can DSIP doses be transferred between routes?

No. Each route and formulation has its own exposure and administration requirements. Use the dose information for the exact presentation rather than copying a tablet, injection or local-product amount to another route.[\[4\]](<https://pepflow.app/peptides/dsip/dosage/#source-4>) [\[1\]](<https://pepflow.app/peptides/dsip/dosage/#source-1>) [\[2\]](<https://pepflow.app/peptides/dsip/dosage/#source-2>) [\[11\]](<https://pepflow.app/peptides/dsip/dosage/#source-11>) [\[6\]](<https://pepflow.app/peptides/dsip/dosage/#source-6>)

### What dosage is listed for DSIP?

Reported-use amounts for DSIP are 100–300 mcg per administration, nightly, for 2–6 wk.[\[12\]](<https://pepflow.app/peptides/dsip/dosage/#source-12>) [\[13\]](<https://pepflow.app/peptides/dsip/dosage/#source-13>)

### Does DSIP have a standard cycle or break interval?

Injectable: 2–6 wk. Intranasal — Deltaran formulation: 5 days. Transdermal — ex vivo iontophoresis: 9-hour sampling period. A standard break interval between courses is not established.[\[12\]](<https://pepflow.app/peptides/dsip/dosage/#source-12>) [\[11\]](<https://pepflow.app/peptides/dsip/dosage/#source-11>) [\[6\]](<https://pepflow.app/peptides/dsip/dosage/#source-6>)

## Sources

- [\[1\] **Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.** Neuropsychobiology, 1992. human clinical.](<https://pubmed.ncbi.nlm.nih.gov/1299794/>)
- [\[2\] **Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.** Eur Neurol, 1987. human clinical.](<https://pubmed.ncbi.nlm.nih.gov/3622582/>)
- [\[3\] **Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study.** Eur Neurol, 1984. human clinical.](<https://pubmed.ncbi.nlm.nih.gov/6548970/>)
- [\[4\] **Search Drugs@FDA for DSIP** U.S. Food and Drug Administration. database query.](<https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm>)
- [\[5\] **Intranasal administration of delta sleep-inducing peptide increases P300.** J Clin Psychopharmacol, 2001 Dec. human clinical.](<https://pubmed.ncbi.nlm.nih.gov/11763019/>)
- [\[6\] **Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide.** Drug development and industrial pharmacy, 1998 May. ex vivo.](<https://pubmed.ncbi.nlm.nih.gov/9876605/>)
- [\[7\] **Delta sleep-inducing peptide.** Eur J Anaesthesiol, 2001 Jul. review.](<https://pubmed.ncbi.nlm.nih.gov/11437870/>)
- [\[8\] **Compounding and the FDA: Questions and Answers** U.S. Food and Drug Administration. official guidance.](<https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers>)
- [\[9\] **Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act** U.S. Food and Drug Administration, 2026-05-14. official guidance.](<https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act>)
- [\[10\] **Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C Act** U.S. Food and Drug Administration, 2025-01-07. regulatory.](<https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503b-fdc-act>)
- [\[11\] **Deltaran official registered instructions** MEDI.RU / Russian Ministry of Health instruction archive, 2017-03-25. reference catalog.](<https://medi.ru/instrukciya/deltaran_19349/>)
- [\[12\] **PepFlow peptide cheat sheet — reported-use and product-orientation reference (not clinical research)** PepFlow. reference catalog.](<https://pepflow.app/peptide-cheat-sheet/>)
- [\[13\] **DSIP — Everything Peptide reported protocol (educational reference, not clinical evidence)** Everything Peptide. reference catalog.](<https://everythingpeptide.com/protocol-dsip.html>)

[Full DSIP library reference →](<https://pepflow.app/peptides/dsip/>)

## Related

- [DSIP Peptide](<https://pepflow.app/peptides/dsip/>)
- [Peptide reconstitution guidelines](<https://pepflow.app/peptide-reconstitution-guidelines/>)
- [How to Calculate Final Concentration: A Practical Guide](<https://pepflow.app/blog/how-to-calculate-final-concentration/>)
- [Peptide Cheat Sheet](<https://pepflow.app/peptide-cheat-sheet/>)
